Core Concept - The Liver's Tollbooth
- Orally administered drugs are absorbed from the GI tract and travel first to the liver via the portal vein before reaching systemic circulation.
- The liver metabolizes a fraction of the drug, reducing its active concentration. This is the First-Pass Effect.
- This process significantly lowers a drug's bioavailability (F).
- Drugs with high first-pass metabolism (e.g., lidocaine, morphine, propranolol) require much larger oral doses than parenteral doses.
⭐ High first-pass metabolism is why drugs like nitroglycerin are given sublingually-bypassing the liver for rapid, direct systemic absorption and higher bioavailability.

Clinical Significance - Dose & Route Roulette
- First-Pass Effect: Orally administered drugs are absorbed from the GI tract and enter portal circulation, passing through the liver before reaching systemic circulation. The liver metabolizes a portion of the drug, reducing its concentration.
- Bioavailability (F): The fraction of administered drug that reaches systemic circulation unchanged. For oral drugs, it's reduced by the first-pass effect.
- Calculated as: $F = f \times (1 - ER)$, where ER is the hepatic extraction ratio.

-
Dose Discrepancy: Drugs with high first-pass metabolism have a much larger oral dose than parenteral dose to achieve equivalent therapeutic effect.
- Examples: Lidocaine, Morphine, Propranolol, Nitroglycerin.
-
Bypassing the Liver: Alternative routes avoid the portal vein and thus, first-pass metabolism.
- Routes: IV, IM, Subcutaneous, Sublingual (SL), Transdermal, Inhalational, and a portion of Rectal (PR) administration.
⭐ Exam Favorite: Nitroglycerin has nearly 100% first-pass metabolism, making oral administration ineffective. It is given sublingually or transdermally for rapid absorption directly into systemic circulation, bypassing the liver for acute angina treatment.
Influencing Factors - The Metabolic Modulators
-
Enzyme Inducers: ↑ rate of drug metabolism → ↓ drug concentration & efficacy.
- 📌 Mnemonic: Guinness, Corona, & PBRS induce Chronic Alcoholism
- Griseofulvin, Carbamazepine, Phenytoin, Barbiturates, Rifampin, St. John's Wort, Chronic alcoholism.
-
Enzyme Inhibitors: ↓ rate of drug metabolism → ↑ drug concentration & risk of toxicity.
- 📌 Mnemonic: CRACK AMIGOS
- Cimetidine/Ciprofloxacin, Ritonavir, Amiodarone, Chloramphenicol, Ketoconazole, Alcohol (acute), Macrolides, Isoniazid, Grapefruit juice, Omeprazole, Sulfonamides.
⭐ Grapefruit juice irreversibly inhibits intestinal wall CYP3A4, markedly ↑ bioavailability of drugs like statins (e.g., atorvastatin, simvastatin) and non-dihydropyridine calcium channel blockers.
High‑Yield Points - ⚡ Biggest Takeaways
- First-pass metabolism is the pre-systemic elimination of a drug, primarily by the liver and gut wall, before reaching systemic circulation.
- It significantly ↓ decreases the oral bioavailability of susceptible drugs.
- Drugs with high extraction ratios (e.g., lidocaine, nitroglycerin) have very low oral bioavailability.
- Routes like IV, sublingual, and transdermal bypass the liver's first pass.
- Liver disease like cirrhosis can reduce first-pass metabolism, increasing drug toxicity risk.
- This necessitates higher oral doses than IV doses for drugs like propranolol.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app